Aberdeen Group
Edinburgh, Scotlandaberdeenplc.com
Overview
Aberdeen Group plc is a United Kingdom-based global investment company that provides asset management and investment services to institutions and private investors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Third Arc Bio | Feb 2026 | Series A Extension | Co-investor |
| Glycomine | Apr 2025 | Series C | - |
| Arbor Biotechnologies | Mar 2025 | Series C | - |
| Aviceda Therapeutics | Jan 2025 | Series C | - |
| Nuvig Therapeutics | Dec 2024 | Series B | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.